Glaucoma is a medical term describing a group of progressive optic neuropathies
characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and …

The present review casts a critical eye on intraocular pressure (IOP) monitoring and its value
in current and future glaucoma care. Crucially, IOP is not fixed, but varies considerably …

Glaucoma therapy-related ocular surface disease (OSD) is a serious pathology with a broad
spectrum of insidious clinical presentations and complex pathogenesis that undermines …

Elevated intraocular pressure (IOP) is a major, and currently the only, modifiable risk factor
that has been shown to reduce the risk of glaucoma onset and progression. Diurnal …

Glaucoma is a progressive, chronic optic neuropathy characterized by a typical visual field
defects. Four main classes of topical medication are actually available on the market: beta …

The key clinical attributes of preserved dorzolamide/timolol fixed combination (DTFC) and
the emerging potential of preservative-free (PF) DTFC are reviewed with published evidence …

Current management of glaucoma entails the medical, laser, or surgical reduction of
intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate …

Purpose To investigate the impact of systolic and diastolic blood pressure (DBP) dip at
baseline on subsequent visual field (VF) progression in eyes with normal-tension glaucoma …

Glaucoma is the leading cause of irreversible blindness worldwide and the prevalence is on
the rising trend. Intraocular pressure (IOP) reduction is the mainstay of treatment. The current …

Glaucoma is a leading cause of visual morbidity throughout the world and is an age-related
condition, the prevalence of which rises significantly with increasing age. Glaucoma, a …